CF rare mutation blood and tissue sample collection study
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 17 or older, and can sign consent (and assent if applicable)
- You have a confirmed CF diagnosis and one of the required CF proof tests or genetic findings
- Your CF is caused by the specific rare CFTR mutation target(s) the study is currently enrolling
- You’re willing to travel to a study site for a rectal biopsy to collect cells
- You’re able to follow study rules and upcoming medication timing instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
This study looks at how where your body stores fat may be linked to changes in metabolism and lung function over time in people with cystic fibrosis. It also compares results with healthy people similar in age, sex, and body size to understand the differences better.
This study tests if people with cystic fibrosis can collect sputum samples at home and mail them in, instead of coming to the clinic. It aims to make participation easier for patients.
This study is a registry that collects health information (and some lab samples) from Chinese children who may have cystic fibrosis (CF). It helps researchers better understand CF in children and how it is diagnosed.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
This study enrolls newly diagnosed infants with cystic fibrosis to follow them during “precision medicine” care. It may help doctors better understand which treatments and monitoring work best, especially before certain infections develop.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.